CYTO Income Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
Report Filing: 2023-06-30 2023-03-31 2023-05-16 2022-09-30 2022-11-30 2022-03-31
1234
Revenue 52735 52735 0 -458691 145399 145399
1234
Cost of Revenue 106091 106091 0 125812 596116 596116
1234
Gross Profit -53356 -53356 0 -584503 -450717 -450717
1234
Operating Expenses 2239819 2239819 -5924875 2541382 3757163 3757164
1234
Research & Development 1130577 1130577 3000751 8056936 1781941 1781942
1234
Selling, General and Administrative 1164945 1164945 1715617 907919 2103132 2103132
1234
Other Operating Expenses -55703 -55703 -10641243 -6423473 -127910 -127910
1234
Operating Income -2293175 -2293175 5924875 -3125885 -4207880 -4207881
1234
Net Interest(Non Operating) -584110.8570955002 266370 146203 267026 -398974 188424
1234
Interest Income 263.1429044998 266370 146203 267026 0 188424
1234
Interest Expense 584374 0 0 0 398974 0
1234
Equity & Other Income/(Expense) 172060.85709550022 -678420 -6852869 -6734309 464553 -122845
1234
Income Before Tax -2705225 -2705225 -781791 -9593168 -4142301 -4142302
1234
Income Tax Expense 5298 5298 20288 17878 23042 23043
1234
Income Attributable to Non-Controlling Interest 0 0 -1 1 -46085 -46087
1234
Net Income -2710523 -2710523 -802078 -9611047 -4119258 -4119258
1234
Depreciation and Amortization 2293175 2293175 45969 222 222 222
1234
EBITDA 0 0 5970844 -3125663 -4207658 -4207659
1234
Earnings Per Share (EPS) -12.91 -12.91 -2.89 -199.86 -106.32 -106.32
1234
Diluted Earnings Per Share -12.91 -12.91 -354.27 -2123.05 -106.32 -106.32
1234
Weighted Average Shares Outstanding 209955 209955 277080 48088 38744 38744
1234
Diluted Weighted Average Shares Outstanding 209955 209955 2264 4527 38745 38745
1234

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.